|
advertisement
|
Company Overview: |
| Araid Pharmaceuticals are engaged in the discovery and development of breakthrough medicines to treat disease by regulating cell signaling with small molecules. Breakthrough medicines are products, created de novo, that may be used to treat diseases in innovative ways. Thier initial disease focus is cancer, and they are developing a comprehensive approach that addresses the greatest medical need – novel therapies for aggressive and advanced-stage disease for which current treatments are inadequate. In oncology, thier goal is to create a series of novel small-molecule product candidates that provide targeted and highly potent anti-cancer activity to treat both solid tumors and hematologic cancers, as well as the spread of primary tumors to distant sites. |
Products and Services: |
| Its lead cancer product candidate, AP23573, is a potent mTOR inhibitor that starves cancer cells and shrinks tumors by regulating the response of tumor cells to nutrients and growth factors and by controlling tumor blood supply and angiogenesis through effects on vascular endothelial growth factor ("VEGF") in tumor and endothelial cells. |
Key Personnel Facts: |
| 72 employees (2004) |
Key Financial Facts: |
| 0.70 M USD (2004) |
Back to Top
|
|
Working @ ARIAD Pharmaceuticals
Have your shout about working or interveiwing at ARIAD Pharmaceuticals
1 message posted
Message Posted:
Working @ ARIAD Pharmaceuticals
Share your experience about working, interveiwing or applying for a job at ARIAD ...
Author: Obi Posted: 10/6/2005 3:37:59 PM |
View or add comments about ARIAD Pharmaceuticals
Back to Top
|
ARIAD Pharmaceuticals in the News
- Ariad Pharmaceuticals Eyes Unit Deal
Published: Thursday, June 21, 2007
- Ariad Pharmaceuticals Eyes Unit Deal (AP)
Published: Thursday, June 21, 2007
- TEXT-Ariad Pharmaceuticals reports Q4 results
Published: Tuesday, February 07, 2006
- TABLE-ARIAD Pharmaceuticals Q4 net loss widens
Published: Tuesday, February 07, 2006
- UPDATE 1-TABLE-ARIAD Pharmaceuticals Q4 net loss widens
Published: Tuesday, February 07, 2006
View more news about ARIAD Pharmaceuticals
Back To Top |
|
ARIAD Pharmaceuticals Journal Citations
View more ARIAD Pharmaceuticals journal citations
Back To Top |
|
|
Categories:
|
Biotechnology
|
|
Back to Top
|
|
|
|